Table of Content

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. Blood plasma products market in India – An overview

Chapter 5: Market segmentation
5.1. Blood plasma products market segmentation – Based on type
5.1.1. India blood plasma products market share by type (%) (2020 and 2025e)
5.1.2. Immunoglobulin
5.1.3. Albumin
5.1.4. Hyperimmune globulins
5.1.5. Coagulation factor VIII
5.1.6. Coagulation factor IX
5.1.7. Other plasma products
5.2. Blood plasma products market segmentation – Based on end users
5.2.1. India blood plasma products market share by end users (%) (2020 and 2025e)
5.2.2. Hospitals
5.2.3. Clinics
5.2.4. Other end users

Chapter 6: Trade analysis
6.1. Export commodity-wise
6.2. Export country-wise
6.3. Import commodity-wise
6.4. Import country-wise

Chapter 7: Impact of COVID-19
7.1. Effect of COVID-19 on the market

Chapter 8: Government initiatives
8.1. Government initiatives

Chapter 9: Market influencers
9.1. Market drivers
9.2. Market challenges

Chapter 10: Competitive landscape
10.1. Bharat Serums and Vaccines Ltd. (BSV)
- Company information
- Business description
- Products/Services
- Key people
Note: Similar information is given for all the companies
10.2. Bioviz Technologies Private Ltd.
10.3. Intas Pharmaceuticals Ltd.
10.4. PlasmaGen BioSciences Private Ltd.
10.5. Plasmatech Solutions Private Ltd.
10.6. Reliance Life Sciences Private Ltd.
10.7. Serum Institute of India Private Ltd.
10.8. Taj Pharma India Ltd.
10.9. Virchow Biotech Private Ltd.
10.10. Zydus Takeda Healthcare Private Ltd.

Chapter 11: Global players
11.1. CSL Behring
11.2. Grifols, S.A.
11.3. Shire Plc
11.4. Octapharma AG

Chapter 12: Recent developments

Chapter 13: Appendix
13.1. Research methodology
13.2. About Netscribes
13.3. Disclaimer